Reges, Orna
Leibowitz, Morton
Hirsch, Avital
Dicker, Dror
Finer, Nick
Haase, Christiane Lundegaard
Satylganova, Altynai
Leventer-Roberts, Maya
Feldman, Becca
Funding for this research was provided by:
Novo Nordisk
Article History
Received: 6 August 2019
Accepted: 14 April 2020
First Online: 8 July 2020
Ethics approval and consent to participate
: This study was approved by Clalit’s institutional review board.
: Not applicable.
: Orna Reges reports no conflicts of interest. Morton Leibowitz reports no conflicts of interest. Avital Hirsch reports no conflicts of interest. Dror Dicker reports no conflicts of interest. Nick Finer is an employee of Novo Nordisk A/S and reports receiving personal fees from Novo Nordisk A/S outside the submitted work. Christiane Lundegaard Haase is an employee of Novo Nordisk A/S and reports receiving personal fees from Novo Nordisk A/S outside the submitted work. Altynai Satylganova is an employee of Novo Nordisk A/S and reports receiving personal fees from Novo Nordisk A/S outside the submitted work. Maya Leventer-Roberts reports no conflicts of interest. Becca Feldman reports no conflicts of interest.